Global Sleep Disorder Market Size, Trends, and Growth Opportunity, By Disorder (Sleep Apnea, Obstructive Sleep Apnea, Central Sleep Apnea, Restless Legs Syndrome, Insomnia, Narcolepsy), By Product (Diagnostics, Therapeutics), By Drug Type (Benzodiazepines, Nonbenzodiazepines, Antidepressants, and Other Drug Types), By End-use (Home Care Settings & Individuals, Sleep Laboratories & Hospitals), Regional Outlook, Competitive Market Share & Forecast, 2022 – 2027.
Global Sleep Disorder Market
The Global Sleep Disorder Market was valued at USD 21.8 billion in 2021 and is expected to reach USD 69.4 billion by 2027, at a CAGR of 18.87% from 2022-2027.
Sleep disorder is insomnia; being unable to fall asleep and stay asleep. This is the most common sleep disorder. Sleep apnea is a breathing disorder in which you stop breathing for 10 seconds and more during sleep.
Common causes of chronic insomnia include stress. Concerns about work, health, finances, and family can keep one’s mind active at night, making it difficult to sleep. Stressful life events & trauma such as death & illness also may lead to insomnia.
Market Drivers
The increase in incidences of sleep disorders, a rise in the geriatric population, an increase in the prevalence of obesity & hypertension, and an increase in awareness among the patient population in developing countries are major factors contributing to the growth of the global sleep disorder market. Aging is also a major factor driving the market growth for sleep disorder devices as the elderly are the most at risk for developing this disorder.
Furthermore, the rising prevalence of sleep disorders and the growing awareness among people about sleep disorders across the globe are contributing to the market's growth.
Market Restraints
Some of the factors such as low diagnosis rate, and side effects of sleep disorder drugs can restrain the global sleep disorder market's growth.
The high cost of sleep disorders or expensive treatment is also a barrier to the market's expansion in the future.
Market Segmentation
The global sleep disorder market is segmented into disorder, product, drug type, end-use, and region.
Based on the disorder, the global sleep disorder market is segmented into sleep apnea, obstructive sleep apnea, central sleep apnea, restless legs syndrome, insomnia, and narcolepsy.
Regional Analysis
The global sleep disorder market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.
The North American region is expected to dominate the sleep disorder market due to the increasing diagnosis rate and awareness about the disease and people having a hectic life schedule. Whereas, the Asia Pacific region is expected to rise due to advancements in new technologies.
Key Players
Various key players are discussed in the global sleep disorder market report including GlaxoSmithKline plc, Becton Dickson and Company, Cardinal Health, Natus Medical Incorporated, Takeda Pharmaceutical Company Limited, Koninklijke Philips N.V., Teva Pharmaceutical Industries Ltd., Jazz Pharmaceuticals, Inc., Pfizer Inc., Viatris Inc., Mylan N.V., and Others.
For Instance, in July 2021, Esai Co. Ltd launched the in-house developed and discovered orexin receptor antagonist DAYVIGO for treating adults with insomnia, characterized by difficulties with sleep onset.
Market Taxonomy
By Disorder
• Sleep Apnea
• Obstructive Sleep Apnea
• Central Sleep Apnea
• Restless Legs Syndrome
• Narcolepsy
• Insomnia
By Product
• Diagnostics
• Therapeutics
By Drug Type
• Benzodiazepines
• Nonbenzodiazepines
• Antidepressants
• Others
By End-use
• Home Care Settings & Individuals
• Sleep Laboratories & Hospitals
By Region
• North America
• Latin America
• Europe
• Asia Pacific
• Middle East & Africa
Global Sleep Disorder Market
1 Introduction
1.1 Objective of the Study
1.2 Market definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Global Sleep Disorder Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Cumulative Impact Due To Recent Energy Crisis
4.2.5 Cumulative Impact Due Nearing Economic Downturn
4.2.6 Post Covid-19 World Supply and Demand Conditions
4.2.7 Cumulative Impact Of Russia-Ukraine Conflict
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global Sleep Disorder Market, By Disorder
5.1 Y-o-Y Growth Comparison, By Disorder
5.2 Global Sleep Disorder Market Share Analysis, By Disorder
5.3 Global Sleep Disorder Market Size and Forecast, By Disorder
5.3.1 Sleep Apnea
5.3.2 Obstructive Sleep Apnea
5.3.3 Central Sleep Apnea
5.3.4 Restless Legs Syndrome
5.3.5 Insomnia, Narcolepsy
6 Global Sleep Disorder Market, By Product
6.1 Y-o-Y Growth Comparison, By Product
6.2 Global Sleep Disorder Market Share Analysis, By Product
6.3 Global Sleep Disorder Market Size and Forecast, By Product
6.3.1 Diagnostics
6.3.2 Therapeutics
7 Global Sleep Disorder Market, By Drug Type
7.1 Y-o-Y Growth Comparison, By Drug Type
7.2 Global Sleep Disorder Market Share Analysis, By Drug Type
7.3 Global Sleep Disorder Market Size and Forecast, By Drug Type
7.3.1 Benzodiazepines
7.3.2 Nonbenzodiazepines
7.3.3 Antidepressants
7.3.4 Others
8 Global Sleep Disorder Market, By End-use
8.1 Y-o-Y Growth Comparison, By End-use
8.2 Global Sleep Disorder Market Share Analysis, By End-use
8.3 Global Sleep Disorder Market Size and Forecast, By End-use
8.3.1 Home Care Settings & Individuals
8.3.2 Sleep Laboratories & Hospitals
9 Global Sleep Disorder Market, By Region
9.1 Global Sleep Disorder Market Share Analysis, By Region
9.2 Global Sleep Disorder Market Share Analysis, By Region
9.3 Global Sleep Disorder Market Size and Forecast, By Region
10 North America Sleep Disorder Market Analysis and Forecast (2022-2027)
10.1 Introduction
10.2 North America Sleep Disorder Market Share Analysis, By Disorder
10.3 North America Sleep Disorder Market Size and Forecast, By Product
10.4 North America Sleep Disorder Market Size and Forecast, By Drug Type
10.5 North America Sleep Disorder Market Size and Forecast, By End-use
10.6 North America Sleep Disorder Market Size and Forecast, By Country
10.6.1 U.S.
10.6.2 Canada
10.6.3 Mexico
11 Europe Sleep Disorder Market Analysis and Forecast (2022-2027)
11.1 Introduction
11.2 Europe Sleep Disorder Market Share Analysis, By Disorder
11.3 Europe Sleep Disorder Market Size and Forecast, By Product
11.4 Europe Sleep Disorder Market Size and Forecast, By Drug Type
11.5 Europe Sleep Disorder Market Size and Forecast, By End-use
11.5 Europe Sleep Disorder Market Size and Forecast, By Country
11.6.1 Germany
11.6.2 France
11.6.3 UK
11.6.4 Rest of Europe
12 Asia Pacific Sleep Disorder Market Analysis and Forecast (2022-2027)
12.1 Introduction
12.2 Asia Pacific Sleep Disorder Market Share Analysis, By Disorder
12.3 Asia Pacific Sleep Disorder Market Size and Forecast, By Product
12.4 Asia Pacific Sleep Disorder Market Size and Forecast, By Drug Type
12.5 Asia Pacific Sleep Disorder Market Size and Forecast, By End-use
12.6 Asia Pacific Sleep Disorder Market Size and Forecast, By Country
12.6.1 China
12.6.2 Japan
12.6.3 India
12.6.4 Rest of Asia Pacific
13 Latin America Sleep Disorder Market Analysis and Forecast (2022-2027)
13.1 Introduction
13.2 Latin America Sleep Disorder Market Share Analysis, By Disorder
13.3 Latin America Sleep Disorder Market Size and Forecast, By Product
13.4 Latin America Sleep Disorder Market Size and Forecast, By Drug Type
13.5 Latin America Sleep Disorder Market Size and Forecast, By End-use
13.6 Latin America Sleep Disorder Market Size and Forecast, Country
13.6.1 Brazil
13.6.2 Rest of Latin America
14 Middle East Sleep Disorder Market Analysis and Forecast (2022-2027)
14.1 Introduction
14.2 Middle East Sleep Disorder Market Share Analysis, By Disorder
14.3 Middle East Sleep Disorder Market Size and Forecast, By Product
14.4 Middle East Sleep Disorder Market Size and Forecast, By Drug Type
14.5 Middle East Sleep Disorder Market Size and Forecast, By End-use
14.6 Middle East Sleep Disorder Market Size and Forecast, By Country
14.6.1 Saudi Arabia
14.6.2 UAE
14.6.3 Egypt
14.6.4 Kuwait
14.6.5 South Africa
15 Competitive Analysis
15.1 Competition Dashboard
15.2 Market share Analysis of Top Vendors
15.3 Key Development Strategies
16 Company Profiles
16.1 GlaxoSmithKline plc
16.1.1 Overview
16.1.2 Offerings
16.1.3 Key Financials
16.1.4 Business Segment & Geographic Overview
16.1.5 Key Market Developments
16.1.6 Key Strategies
16.2 Becton Dickson and Company
16.2.1 Overview
16.2.2 Offerings
16.2.3 Key Financials
16.2.4 Business Segment & Geographic Overview
16.2.5 Key Market Developments
16.2.6 Key Strategies
16.3 Cardinal Health
16.3.1 Overview
16.3.2 Offerings
16.3.3 Key Financials
16.3.4 Business Segment & Geographic Overview
16.3.5 Key Market Developments
16.3.6 Key Strategies
16.4 Natus Medical Incorporated
16.4.1 Overview
16.4.2 Offerings
16.4.3 Key Financials
16.4.4 Business Segment & Geographic Overview
16.4.5 Key Market Developments
16.4.6 Key Strategies
16.5 Takeda Pharmaceutical Company Limited
16.5.1 Overview
16.5.2 Offerings
16.5.3 Key Financials
16.5.4 Business Segment & Geographic Overview
16.5.5 Key Market Developments
16.5.6 Key Strategies
16.6 Koninklijke Philips N.V.
16.6.1 Overview
16.6.2 Offerings
16.6.3 Key Financials
16.6.4 Business Segment & Geographic Overview
16.6.5 Key Market Developments
16.6.6 Key Strategies
16.7 Teva Pharmaceutical Industries Ltd.
16.7.1 Overview
16.7.2 Offerings
16.7.3 Key Financials
16.7.4 Business Segment & Geographic Overview
16.7.5 Key Market Developments
16.7.6 Key Strategies
16.8 Jazz Pharmaceuticals, Inc.
16.8.1 Overview
16.8.2 Offerings
16.8.3 Key Financials
16.8.4 Business Segment & Geographic Overview
16.8.5 Key Market Developments
16.8.6 Key Strategies
16.9 Pfizer Inc.
16.9.1 Overview
16.9.2 Offerings
16.9.3 Key Financials
16.9.4 Business Segment & Geographic Overview
16.9.5 Key Market Developments
16.9.6 Key Strategies
16.10 Mylan N.V.
16.10.1 Overview
16.10.2 Offerings
16.10.3 Key Financials
16.10.4 Business Segment & Geographic Overview
16.10.5 Key Market Developments
16.10.6 Key Strategies
